Backman v. Takeda Pharmaceutical Company Limited

Filing 19

ORDER granting 18 Motion to Stay - All discovery, including this Court's December 19, 2011 Initial Order Regarding Planning and Scheduling, is hereby stayed in the United States District Court for the Eastern District of North Carolina, so that discovery may proceed in this action in the Actos MDL, subject to further proceedings not inconsistent with the Actos MDL upon any remand from the MDL. Signed by District Judge Louise Wood Flanagan on 12/27/2011. (Baker, C.)

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF NORTH CAROLINA
SOUTHERN DIVISION

PEGGYE BACKMAN,

Plaintiff,
Civil Action No. 7:11-cv-212-FL

v.
TAKEDA PHARMACEUTICAL
COMPANY LIMITED, flk/a TAKEDA
CHEMICAL INDUSTRIES, LTD.;
TAKEDA PHARMACEUTICALS
NORTH AMERICA, INC.; TAKEDA
PHARMACEUTICALS AMERICA,
INC.; TAKEDA GLOBAL RESEARCH
& DEVELOPMENT CENTER, INC.;
ELI LILLY AND COMPANY,

Defendants.

ORDER FOR STAY OF DISCOVERY DUE TO

CASE STATUS AND ANTICIPATED FORMATION OF MDL

This matter comes before this Court upon the Joint Motion of Plaintiff and
Defendants for a stay of discovery due to the status of this case and the anticipated
formation of an Actos multidistrict litigation ("MOL").
Having examined the Joint Motion of the parties, the Court now finds that for
good cause shown, the Motion should be GRANTED and hereby Orders the following:

All discovery, including this Court's December 19,2011 Initial Order Regarding
Planning and Scheduling, is hereby stayed in the United States District Court for the
Eastern District of North Carolina, so that discovery may proceed in this action in the
Actos MDL, subject to further proceedings not inconsistent with the Actos MDL upon
any remand from the MDL.
SO ORDERED, this

11"dayof t>ttt~O~

_.nt.... ,__

FLA~~

HON. LOUISE W.
United States District Court Judge